{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T13:04:11Z","timestamp":1791291851107,"version":"4.1.0"},"reference-count":37,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2006,11,1]],"date-time":"2006-11-01T00:00:00Z","timestamp":1162339200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2006,11,1]],"date-time":"2006-11-01T00:00:00Z","timestamp":1162339200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transfusion Clinique et Biologique"],"published-print":{"date-parts":[[2006,11]]},"DOI":"10.1016\/j.tracli.2006.11.003","type":"journal-article","created":{"date-parts":[[2006,12,23]],"date-time":"2006-12-23T07:14:17Z","timestamp":1166858057000},"page":"298-303","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["\u00c9valuation du\u00a0risque transfusionnel vis-\u00e0-vis de\u00a0la\u00a0variante de\u00a0la\u00a0maladie de\u00a0Creutzfeldt-Jakob en\u00a0France"],"prefix":"10.1016","volume":"13","author":[{"given":"M.","family":"Martin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.-F.","family":"Legras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Pouchol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.-H.","family":"Trouvin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tracli.2006.11.003_bib1","series-title":"Analyse du risque de transmission de la nouvelle variante de la maladie de Creutzfeldt-Jakob par le sang et ses d\u00e9riv\u00e9s \u2013 Recommandations \u2013 d\u00e9cembre 2000","year":"2000"},{"key":"10.1016\/j.tracli.2006.11.003_bib2","series-title":"Analyse du risque de transmission de la variante de la maladie de Creutzfeldt-Jakob par les m\u00e9dicaments d'origine humaine et par les produits sanguins labiles \u2013 Actualisation des donn\u00e9es du rapport du groupe ad hoc de d\u00e9cembre 2000 \u2013 f\u00e9vrier 2002","year":"2002"},{"key":"10.1016\/j.tracli.2006.11.003_bib3","series-title":"Analyse du risque de transmission de la variante de la maladie de Creutzfeldt-Jakob par les m\u00e9dicaments d'origine humaine et par les produits sanguins labiles \u2013 Actualisation des donn\u00e9es du rapport du groupe ad hoc de d\u00e9cembre 2000 \u2013 mars 2003","year":"2003"},{"key":"10.1016\/j.tracli.2006.11.003_bib4","series-title":"Analyse du risque de transmission de la variante de la maladie de Creutzfeldt-Jakob par les produits de sant\u00e9 et par les tissus et fluides d'origine humaine \u2013 Actualisation des donn\u00e9es du rapport du groupe ad hoc de d\u00e9cembre 2000 \u2013 F\u00e9vrier 2004","year":"2004"},{"key":"10.1016\/j.tracli.2006.11.003_bib5","series-title":"\u00c9valuation du risque de transmission de l'agent de Creutzfeldt-Jakob par le sang et ses composants \u2013 R\u00e9union du groupe d'experts du 16 novembre 2004 \u2013 F\u00e9vrier 2005","year":"2005"},{"key":"10.1016\/j.tracli.2006.11.003_bib6","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/S0140-6736(98)12075-5","article-title":"Investigation of variant Creutzfeldt-Jakob disease and other human prion diseases with tonsil biopsy samples","volume":"353","author":"Hill","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.tracli.2006.11.003_bib7","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.1016\/S0002-9440(10)64474-4","article-title":"Disease-associated prion protein in vessel walls","volume":"161","author":"Koperek","year":"2002","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.tracli.2006.11.003_bib8","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S0002-9440(10)63105-7","article-title":"Peripheral tissue involvement in sporadic, iatrogenic, and variant Creutzfeldt-Jakob disease: an immunohistochemical, quantitative, and biochemical study","volume":"164","author":"Head","year":"2004","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.tracli.2006.11.003_bib9","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1046\/j.1537-2995.2002.00098.x","article-title":"Brain and buffy coat transmission of bovine spongiform encephalopathy to the primate Microcebus murinus","volume":"42","author":"Bons","year":"2002","journal-title":"Transfusion"},{"key":"10.1016\/j.tracli.2006.11.003_bib10","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1111\/j.1423-0410.2005.00683.x","article-title":"Blood infectivity, processing and screening tests in transmissible spongiform encephalopathy","volume":"89","author":"Brown","year":"2005","journal-title":"Vox Sang."},{"key":"10.1016\/j.tracli.2006.11.003_bib11","doi-asserted-by":"crossref","first-page":"2897","DOI":"10.1099\/0022-1317-83-11-2897","article-title":"Transmission of prion diseases by blood transfusion","volume":"83","author":"Hunter","year":"2002","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.tracli.2006.11.003_bib12","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1126\/science.1129051","article-title":"Presymptomatic detection of prions in blood","volume":"313","author":"Saa","year":"2006","journal-title":"Science"},{"key":"10.1016\/j.tracli.2006.11.003_bib13","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1046\/j.0041-1132.2003.00586.x","article-title":"Similar levels of infectivity in the blood of mice infected with human-derived vCJD and GSS strains of transmissible spongiform encephalopathy","volume":"43","author":"Cervenakova","year":"2003","journal-title":"Transfusion"},{"key":"10.1016\/j.tracli.2006.11.003_bib14","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1046\/j.1537-2995.1998.38998408999.x","article-title":"The distribution of infectivity in blood components and plasma derivatives in experimental models of transmissible spongiform encephalopathy","volume":"38","author":"Brown","year":"1998","journal-title":"Transfusion"},{"key":"10.1016\/j.tracli.2006.11.003_bib15","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/S0140-6736(04)16812-8","article-title":"Effectiveness of leucoreduction for removal of infectivity of transmissible spongiform encephalopathies from blood","volume":"364","author":"Gregori","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.tracli.2006.11.003_bib16","doi-asserted-by":"crossref","first-page":"4142","DOI":"10.1073\/pnas.041490898","article-title":"Adaptation of the bovine spongiform encephalopathy agent to primates and comparison with Creutzfeldt-Jakob disease: implications for human health","volume":"98","author":"Lasmezas","year":"2001","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.tracli.2006.11.003_bib17","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/S0140-6736(04)15487-1","article-title":"Tissue distribution of bovine spongiform encephalopathy agent in primates after intravenous or oral infection","volume":"363","author":"Herzog","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.tracli.2006.11.003_bib18","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1016\/S0140-6736(00)02719-7","article-title":"Transmission of BSE by blood transfusion in sheep","volume":"356","author":"Houston","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.tracli.2006.11.003_bib19","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1182\/blood-2005-12-5156","article-title":"The neuropathologic phenotype of experimental ovine BSE is maintained after blood transfusion","volume":"108","author":"Siso","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.tracli.2006.11.003_bib20","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1002\/ana.410350504","article-title":"Human spongiform encephalopathy: the National Institutes of Health series of 300 cases of experimentally transmitted disease","volume":"35","author":"Brown","year":"1994","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.tracli.2006.11.003_bib21","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/S0140-6736(94)91148-7","article-title":"Creutzfeldt-Jakob disease and blood transfusion","volume":"343","author":"Heye","year":"1994","journal-title":"Lancet"},{"key":"10.1016\/j.tracli.2006.11.003_bib22","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1046\/j.1537-2995.1998.38998409000.x","article-title":"Surveillance for Creutzfeldt-Jakob disease among persons with haemophilia","volume":"38","author":"Evatt","year":"1998","journal-title":"Transfusion"},{"key":"10.1016\/j.tracli.2006.11.003_bib23","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1136\/bmj.321.7252.17","article-title":"Risk of acquiring Creutzfeldt-Jakob disease from blood transfusions: systematic review of case-control studies","volume":"321","author":"Wilson","year":"2000","journal-title":"BMJ"},{"key":"10.1016\/j.tracli.2006.11.003_bib24","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1136\/bmj.332.7551.1164","article-title":"A new human genotype prone to variant Creutzfeldt-Jakob disease","volume":"332","author":"Wilson","year":"2006","journal-title":"BMJ"},{"key":"10.1016\/j.tracli.2006.11.003_bib25","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/S0140-6736(04)15486-X","article-title":"Possible transmission of variant Creutzfeldt-Jakob disease by blood transfusion","volume":"363","author":"Llewelyn","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.tracli.2006.11.003_bib26","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/S0140-6736(04)16811-6","article-title":"Preclinical vCJD after blood transfusion in a PRNP codon 129 heterozygous patient","volume":"364","author":"Peden","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.tracli.2006.11.003_bib27","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1111\/j.1423-0410.2006.00833.x","article-title":"Creutzfeldt-Jakob disease and blood transfusion: results of the UK Transfusion Medicine Epidemiological Review study","volume":"91","author":"Hewitt","year":"2006","journal-title":"Vox Sang."},{"key":"10.1016\/j.tracli.2006.11.003_bib28","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S1631-0691(02)01410-5","article-title":"Predicting the size of the vCJD epidemic in France","volume":"325","author":"Alperovitch","year":"2002","journal-title":"C. R. Biol."},{"key":"10.1016\/j.tracli.2006.11.003_bib29","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1038\/35020688","article-title":"Predicted vCJD mortality in Great Britain","volume":"406","author":"Ghani","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.tracli.2006.11.003_bib30","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1098\/rsif.2004.0017","article-title":"Projections of the future course of the primary vCJD epidemic in the UK: inclusion of subclinical infection and the possibility of wider genetic susceptibility","volume":"2","author":"Clarke","year":"2005","journal-title":"J. R. Soc. Interface"},{"key":"10.1016\/j.tracli.2006.11.003_bib31","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1093\/ije\/dyg248","article-title":"Predicting incidence of variant Creutzfeldt-Jakob disease from UK dietary exposure to bovine spongiform encephalopathy for the 1940 to 1969 and post-1969 birth cohorts","volume":"32","author":"Cooper","year":"2003","journal-title":"Int. J. Epidemiol."},{"key":"10.1016\/j.tracli.2006.11.003_bib32","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1093\/ije\/dyg276","article-title":"Commentary: Predicting the unpredictable: the future incidence of variant Creutzfeldt-Jakob disease","volume":"32","author":"Ghani","year":"2003","journal-title":"Int. J. Epidemiol."},{"key":"10.1016\/j.tracli.2006.11.003_bib33","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1191\/0962280203sm329ra","article-title":"Modelling the epidemic of variant Creutzfeldt-Jakob disease in the UK based on age characteristics: updated, detailed analysis","volume":"12","author":"Boelle","year":"2003","journal-title":"Stat. Methods Med. Res."},{"key":"10.1016\/j.tracli.2006.11.003_bib34","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.1126\/science.1066838","article-title":"Estimation of epidemic size and incubation time based on age characteristics of vCJD in the United Kingdom","volume":"294","author":"Valleron","year":"2001","journal-title":"Science"},{"key":"10.1016\/j.tracli.2006.11.003_bib35","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1126\/science.1064748","article-title":"Predictability of the UK variant Creutzfeldt-Jakob disease epidemic","volume":"294","author":"d'Aignaux","year":"2001","journal-title":"Science"},{"key":"10.1016\/j.tracli.2006.11.003_bib36","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1191\/0962280203sm330ra","article-title":"Estimation of the exposure of the French population to the BSE agent: comparison of the 1980\u20131995 consumption of beef products containing mechanically recovered meat in France and the UK, by birth cohort and gender","volume":"12","author":"Chadeau-Hyam","year":"2003","journal-title":"Stat. Methods Med. Res."},{"key":"10.1016\/j.tracli.2006.11.003_bib37","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1093\/ije\/dyh374","article-title":"Risk of variant Creutzfeldt-Jakob disease in France","volume":"34","author":"Chadeau-Hyam","year":"2005","journal-title":"Int. J. Epidemiol."}],"container-title":["Transfusion Clinique et Biologique"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1246782006001455?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1246782006001455?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T10:27:42Z","timestamp":1761128862000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1246782006001455"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,11]]},"references-count":37,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2006,11]]}},"alternative-id":["S1246782006001455"],"URL":"https:\/\/doi.org\/10.1016\/j.tracli.2006.11.003","relation":{},"ISSN":["1246-7820"],"issn-type":[{"value":"1246-7820","type":"print"}],"subject":[],"published":{"date-parts":[[2006,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"\u00c9valuation du\u00a0risque transfusionnel vis-\u00e0-vis de\u00a0la\u00a0variante de\u00a0la\u00a0maladie de\u00a0Creutzfeldt-Jakob en\u00a0France","name":"articletitle","label":"Article Title"},{"value":"Transfusion Clinique et Biologique","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tracli.2006.11.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2007 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}